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Development of an in vitro method for the prediction of mycotoxin 
binding on yeast-based products: case of aflatoxin Bi , zearalenone 
and ochratoxin A 
Virginie Faucet-Marquis • Claire Joannis-Cassan • 
Kheira Hadjeba-Medjdoub • Nathalie Ballet• Annie Pfohl-Leszkowicz 
Abstract To date, no official method is available to accurate­
ly define the binding capacity ofbinders. The goal is to define 
general in vitro parameters ( equilibrium time, pH, mycotoxin/ 
binder ratio) for the determination ofbinding efficacy, which 
can be used to calculate the relevant equilibrium adsorption 
constants. For this purpose, aflatoxin B1 (AFB1), zearalenone 
(ZEA) or ochratoxin A (OTA) were incubated with one yeast 
cell wall in pH 3, pH 5 or pH 7 buffers. The percentage of 
adsorption was recorded by quantitation of remaining myco­
toxins in the supernatant and amount of mycotoxin adsorbed 
on the residue. The incubation of yeast cell wall in the pres­
ence of mycotoxins solved in buffer, lead to unexpected high 
adsorption percentage when the analysis was based only on 
remaining mycotoxins in the supematant. The decrease of 
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mycotoxins in the supematant was not correlated to the 
amount of mycotoxins found in the residue. For this reason 
we modified the conditions of incubation. Yeast cell wall 
(5 mg) was pre-incubated in buffer (990 µl) at 37 °C during 
5 min and then 10 µl of an alcoholic solution of mycotoxin 
( concentration 100 times higher than the final concentration 
required in the test tube) were added. After incubation, the 
solution was centrifuged, and the amount of mycotoxins were 
analysed both in the supernatant and in the residue. A plateau 
of binding was reached after 15 min of incubation whatever 
the mycotoxins and the concentrations tested. The adsorption 
of ZEA was better at pH 5 (75 % ), versus 60 % at pH 3 and 7. 
OTA was only significantly adsorbed at pH 3 (50 %). 
Depending on the pH, the adsorptions of OTA or ZEA were 
increased or decreased when they were together, indicative of 
a cooperative effect. 
Keywords Binder • Aflatoxin • Ochratoxin • Zearalenone • 
Yeast • In vitro screening method 
Introduction 
Mycotoxins are fungal secondary metabolic products growing 
on a variety of crops. These compounds pose a potential threat 
to human and animal health through the ingestion of food or 
feed Yannikouris and Jouany (2002). Aflatoxin B1 (AFB1) is a 
potent human carcinogen (group 1) (International Agency for 
Research on Cancer [IARC] 1993) mainly produced by 
Aspergillus jlavus and A. parasiticus. Aflatoxin contamination 
occurs frequently in agricultural products, particularly in 
maize and groundnuts. This mycotoxin is a potent liver toxin 
that can be lethal when consumed in large amount, and it 
induces cancer by chronic exposure. Ochratoxin A (OTA) 
produced by several Aspergillus and some Penicillium species 
(Varga et al. 2003; Ostry et al. 2013), is a main contaminant of 
cereals ( corn, barley, wheat) and to some extent beans ( coffee, 
soy, cocoa). The IARC rated OTA as a possible carcinogen 
(group 2B) (IARC 1993). The presence of OTA in several 
commodities (feed, food and beverages) is considered as a 
serious health hazard in view of its nephrotoxic, teratogenic, 
hepatotoxic and carcinogenic properties (Varga et al. 2001; 
Pfohl-Leszkowicz and Manderville 2007, 2012). Zearalenone 
(ZEA), produced by numerous Fusarium species, exhibits an 
estrogenic activity (Mirocha et al. 1971). It contaminates 
grains (wheat, barley, sorghum and corn) and fiuits. ZEA is 
frequently implicated in reproductive disorders or physical 
changes in genital organs of farm animals (Zinedine et al. 
2007; Fink-Gremmels and Malekinejad 2007). 
Primary strategies to reduce the risk of mycotoxin contam­
ination include good agricultural practices in the field ( crop 
rotation, soil cultivation, weed and insect control, careful use 
offungicides) and upon harvest, as well as transportation and 
storage under dry and cool conditions (Jouany 2007). 
However, complete avoidance of mycotoxins is not possible. 
Severa} approaches have been investigated to reduce the 
risk of mycotoxicosis in livestock (Jouany 2007; Kolosova 
and Stroka 2011 ). Biological, chemical, or physical treatments 
can minimize toxin production and eliminate contaminants in 
food and feed.  The most applied method to prevent 
mycotoxicosis in animals consists in the addition of adsor­
bents to animal feed, in order to bind the mycotoxins in the 
gastro-intestinal tract (Regulation EC No. 386/2009). The 
e:fficacy ofbinders appears to depend on the chemical structure 
ofboth the adsorbent and the mycotoxin. The most important 
feature is the physical structure of the adsorbent, i.e., the total 
charge and charge distribution, the size of the pores and the 
accessible surface area (Di Natale et al. 2009). On the other 
hand, the properties of the adsorbed mycotoxins, like polarity, 
solubility, shape and charge distribution, also play a significant 
role (Huwig et al. 2001; Avantaggiato et al. 2005). 
Silicates are the most widespread commercially available 
feed additives for mycotoxins binding. Minerai adsorbents 
such as clays or activated carbons have been extensively 
tested for their potential to bind aflatoxin and impair their 
gastrointestinal absorption (Kabak et al. 2006). However, 
these compounds are relatively ine:fficient toward others my­
cotoxins and can also impair the absorption of some 
micronutrients (Huwig et al. 2001). 
Organic adsorbents such as yeast cell wall (YCW) both 
in vitro and in vivo have shown much larger sorption capa­
bilities across a wider spectrum ofmycotoxins (Binder 2007; 
Huwig et al. 2001; Jouany 2007; Yiannikouris et al. 2004, 
2006, 2013; Karaman et al. 2005; Kabak et al. 2006; 
Kabak and Dobson 2009; Shetty and Jespersen 2006; Shetty 
et al. 2007; Ringot et al. 2007; Sabater-Vilar et al. 2007; 
Korosteleva et al. 2007; Matur et al. 2010; Firmin et al. 
2010, 2011; Joannis-Cassan et al. 2011). Saccharomyces 
cerevisiae occurs as part of natural microbial population in 
food fermentation and as starter cultures in the food and 
beverage industries. Yeast glucans are major cell wall compo­
nents often present as the inner wall layer and associated with 
other cell wall components such as chitin (together, they 
represent 50--60 % of the wall dry weight) which insured the 
mechanical strength (physical protection and osmotic sup­
port). The outer cell wall layer is made ofheavily glycosylated 
mannoproteins, which are involved in cell--cell recognition 
events and limitation of wall porosity (Kollar et al. 1997; 
Manners et al. 1973; Zekovic et al. 2005). 
Adsorption on the cell wall surface is an interaction be­
tween the toxins and functional groups of the cell surface, 
based on physical adsorption, ion exchange and complexa­
tion. The cell walls harbouring polysaccharides (glucan, man­
nan), proteins and lipids exhibit numerous different and easily 
accessible adsorption centers as well as different binding 
mechanisms (i.e., hydrogen bonds, ionic or hydrophobie in­
teractions; Huwig et al. 2001; Ringot et al. 2007). The 
mannoproteins contain hydrophobie domain enabling hydro­
phobie interactions to occur with OTA especially at the pH of 
the YCW adsorption system (pH 3) where OTA is mainly in 
its non-ionized form (Ringot et al. 2005). The measurement of 
enthalpy/entropy of OTA adsorption on YCW suggested a 
possible role of the phenylalanine moiety of OTA (Ringot 
et al. 2005). OTA biosorption onto YCW involves both polar 
and non-polar non-covalent interactions and the concomitant 
reorganization of the water molecules of the solvent. The non­
polar interactions involve the aromatic rings of OTA and 
hydrophobie amino acids of yeast. The polar interactions can 
be explained in different complementary ways: (1) electrostat­
ic ionic interactions involving carboxyl group of OTA and 
basic amino acids of YCW, (2) electrostatic n-n interactions 
involving aromatic ring of OTA and aromatic amino acids of 
YCW, (3) hydrogen bounds of OTA phenol and amide group 
as donor and acceptor group ofYCW, ( 4) hydrogen bounds of 
OTA involving aromatic rings as acceptors interacting with 
donor groups ofYCW (Ringot et al. 2005). 
The beta-glucan fraction ofYCW is directly involved in the 
binding strength (Jouany 2007; Shetty and Jespersen 2006; 
Yiannikouris et al. 2004). Carvet et al. (2010) tested different 
/3-glycans and showed that the bound type (1-3 or 1-6) or 
ramification might not be su:fficient to characterize their ad­
sorption properties. The binding e:fficiency is a more quanti­
tative phenomenon (large surface area) than a qualitative 
phenomenon (chemical structure involved in the interaction), 
and in this sense the analysis of the glucomannan and pepti­
doglycan chemical structures did not indicate major differ­
ences in the capacity to produce hydrophobie interactions or 
hydrogen bonds, which are presumably involved in the bind­
ing (Pizzolitto et al. 2011). The interaction between /3-0-
glucans and the mycotoxins is driven by steric complemen­
tarities enabling a marked involvement of van der Waals 
interaction causing some stacking effects as well as stable 
intermolecular hydrogen bonding involving the hydroxyl, 
lactone, and ketone groups commonly found on mycotoxins. 
(1-3)- (3-o-Glucans were involved in both mechanisms, 
whereas (1-6)-(3-o-glucans seemed to strengthen the van der 
Waals bonds and consequently to strongly stabilize the toxin­
glucan interaction. However, the mycotoxins were not all 
equivalent in their ability to bind with (3-o-glucans. Also, 
the environmental conditions such as pH were determining 
for the stability of the toxin-glucan complexes generated. The 
stereo-chemistry and hydrophobie properties of mycotoxins 
are of prime importance and account for the differences in 
their a:tfmity for (3-o-glucans (Yiannikouris et al. 2006). The 
cell diameter/cell wall thickness relation showed a correlation 
between cell wall amount and mycotoxin removal ability 
(Armando et al. 2012). 
The obvious advantage of in vitro model is the possibility 
to rapidly screen the efficacy of high numbers of different 
substances enabling a pre-selection of products. 
The experimental conditions for in vitro experiments re­
ported in literature are often not sufficiently described to be 
reproduced or the designs are very different (e.g., pH, filtra­
tion versus centrifugation for binder/toxin separation, one 
single concentration or equilibrium point, percentage ofbind­
er, concentration of the toxin, incubation parameters )impeding 
comparison of the results. Until now, no official method is 
available to accurately defme the adsorption capacity ofyeast 
products. Only some guidelines have been recently published 
(EFSA 2009). The aim of this work was to test different 
conditions to define a protocol which is reproducible. In the 
end, as a validation of the protocol several yeast-based prod­
ucts were tested for their ability to bind together AFB1, OTA 
andZEA. 
Material and methods 
Binders 
The binding material used to develop the in vitro procedure 
was YCW from baker industry called Y0. This YCW contains 
27.1 g/100 g ofproteins, 14.5 g/100 g oflipids, 27.1 g/100 g 
of mannans, 20.1 g/100 g of glucans, with a ration Mannans/ 
Glucans of 1.08. Eight other binders including inactivated 
yeasts and yeast cell walls from baker and brewer yeast 
industries have been used to validate the new protocol. The 
products were labelled with a letter code (Yl to Y8), and some 
of their characteristics including proteins contents and lipids 
are summarized in Table S 1. 
Chemicals 
AFB1 , OTA, ZEA were supplied by Sigma-Aldrich (France). 
All chemicals used were of analytical grade unless otherwise 
stated. All sol vents (HPLC grade) were purchased from ICS 
(France). 
The binding of mycotoxins was studied under three differ­
ent pHs: pH 3 (citrate buffer), pH 5 (acetate buffer) and pH 7 
(phosphate buffer). These pHs were chosen to determine the 
effects of pH on mycotoxin binding within the range found in 
the gastrointestinal tract. 
Preparations of the bujfers 
Citrate buffer (pH 3), 0.1 mol/1: 4.27 g of tri-sodium citrate 
2-hydrate (C6H5Na3O,2H2O, MW=294.l) were dissolved
in approximately 900 ml of distilled water. Tuen, the solution
was adjusted to pH 3 with 17.96 g of citric acid (C6H8O,
H2O, MW = 210.13, d=l.5) and filled up to 1,000 ml with
distilled water.
Acetate buffer (pH 5), 0.1 mol/1: 13.608 g of sodium 
acetate 3-hydrate (C2H3NaOz-3H2O, MW = 136.08) were dis­
solved in approximately 900 ml of distilled water. Then, the 
solution was adjusted to pH 3 with acetic acid (C2H4O2 , 
MW=60.05, d= 1.05) and filled up to 1000 ml with distilled 
water. 
Phosphate buffer (pH 7), 0.1 mol/1: a 0.1 mol/1 solution of 
sodium di-hydrogen phosphate 2-hydrate was prepared by 
dissolving 15.601 g of NaH2PO4-2H2O (MW =l56.0l) in 
1,000 ml of distilled water. A 0.1 mol/1 solution of di­
sodium hydrogen phosphate 12-hydrate was prepared by dis­
solving 35.814 g of Na2HPOçl2H2O (MW = 358.14) in 
1,000 ml of distilled water. Tuen, the Na2HPO4 solution was 
adjusted to pH 7 by adding the NaH2PO4 solution. 
Incubation conditions for optimisation of the method 
Preliminary testslevaluation of the relative concentrations 
mycotoxin/yeast both solved in buffers 
The YCW numbered Y0 (1, 5, 50 mg/ml) was incubated 
during 90 min at 37 °C in the presence of AFB1 (2 µg/ml) 
or ZEA (20 µg/ml) dissolved in the buffers. The adsorption 
was compared to control tube containing buffer (pH 3, 5, 7) 
and either 2 µg of AFB1 or 20 µg of ZEA solved in the buffer 
(final volume= 1 ml). After 90 min of incubation at 37 °C 
under shaking, the mixture was centrifuged 10 min at 
9,200xg. The amount of unbound mycotoxins was deter­
mined without any extraction directly in the supematant and 
the adsorbed mycotoxin was determined after extraction in the 
residue. Data are expressed as the mean value of three incu­
bations per conditions. 
Kinetic of adsorption 
YCW (Y0, 5 mg) was pre-incubated during 5 min in the 
presence of 990 µ1 of buffer (pH= 3, 5, 7). Then 10 µ1 
mycotoxins solved in methanol (100 titnes higher than final 
concentration required in the test tube) were added. The 
amounts of mycotoxins in 1 ml (final volume) were 0.5 or 
10 µg for either AFB1 or OTA; 1 or 50 µg for ZEA. The 
mixture was shaken from 0 to 90 min at 3 7 °C, and centrifuged 
as described above. The amount of unbound mycotoxins was 
determined without any extraction directly in the supernatant 
and the adsorbed mycotoxin was determined after extraction 
in the residue. Data are expressed as the mean value of three 
incubations per conditions. 
Equilibrium point 
YCW (Y0, 5 mg) was pre-incubated for 5 min in the presence 
of990 µl ofbuffer (pH=3, 5, 7). Tuen increasing amounts of 
mycotoxins solved in methanol (10 µl) were added. The 
amounts of OTA tested in 1 ml were 0.05, 0.5, 2, 5, 10 µg; 
and for ZEA l, 5, 20, 50, 80 µg. The mixture was shaken 
15 min at 37 °C and centrifuged 10 min at 9,200xg. The 
amount ofunbound mycotoxins was determined without any 
extraction directly in the supematant and the adsorbed myco­
toxin was determined after extraction in the residue. 
Simultaneous binding of the three mycotoxins 
YCW (Y0, 5 mg) was pre-incubated during 5 min in the 
presence of 990 µl of buffer (pH 3, 5). Then, 10 µl of 
methanol mycotoxin solution ( concentration 100 titnes higher 
than final concentration requited in the test tube) was added. 
Two different mixtures of mycotoxins were tested: (1) ZEA 
(1 µg/ml)+OTA (0.5 µg/ml)+ AFB1 (0.5 µg/ml); (2) ZEA 
(20 µg/ml)+OTA (2 µg/ml)+ AFB1 (2 mg/ml). The mixture 
was shaken15 min at 37 °C and centrifuged 10 min at 
9,200xg. The amount of unbound mycotoxins was deter­
mined without any extraction directly in the supematant and 
the adsorbed mycotoxin was determined after extraction in the 
residue. Data are expressed as the mean value of three incu­
bations per conditions. 
Evaluation ofbinding capacities of eight yeast-based products 
compared to Y0 
To validate the new method, comparison ofbinding capacities 
of eight yeast-based products (Yl-Y8) against AFB1 , OTA, 
ZEA - alone or in combination - was done and compared 
to Y0 ( called Y9) as described in the following paragraphs. 
Five milligrams of each yeast-based product was pre­
incubated during 5 min in the presence of 990 µl of buffer 
pH 3 ( citrate buffer). Tuen, 10 µl of methanol mycotoxin 
solutions ( at concentration 100 titnes higher than the final 
concentration required in the test tube) was added. 
The amount of ZEA was 20 µg/ml; the amount of AFB1 or 
OTA was 0.5 µg/ml. Two different mixtures of mycotoxins 
were tested: (1) ZEA (20 µg/ml)+ AFB 1 (0.5 µg/ml); (2) ZEA 
(20 µg/ml)+AFBl (0.5 µg/ml)+OTA (0.5 µg/ml) 
The mixtures were shaken 15 min at 3 7 °C and centrifuged 
10 min at 9,200xg. The amount of mycotoxins was de­
termined in the supematant without any extraction and 
on the residue after extraction. The % of binding were 
calculated using the both results, taking as reference the 
amount of mycotoxin engaged and measured in the 
control tube. Activated carbon was tested as reference 
binding substance for each mycotoxin. Data are 
expressed as the mean value of three incubations per 
conditions. 
Extraction of mycotoxin from residue 
Extraction of OTA 
OTA was extracted from residue by 900 µl of the following 
mixture MgClz (0.2 M)/HCL (1 M) vol/vol. Chloroform 
(900 µl) was added to the mixture and shaken for 10 min. 
After 10 min of centrifugation at 4 °C, and 10,000xg, the 
aqueous phase was isolated. The chloroform phase (at the 
bottom of the tube) containing the mycotoxins was taken off 
and kept in a new tube for following purification. Again, 
900 µl of chloroform was added to the aqueous phase, shaken 
for 10 min, and centrifuged for the collection of the chloro­
form phase, which was added to the previous one. The chlo­
roform phase was evaporated to dryness. The dry extract was 
dissolved in 1 ml methanol and put in ultrasonic bath for 
1 min. The solution was filtered on a filter SPARTAN 
0.2 µm. Before adding the solution, the filter received 
500 µl of methanol. After the solution pass through the filter, 
500 µl methanol was added again. The methanol was evapo­
rated to dryness under nitrogen. Finally, the extract was solved 
in 300 µl of methanol, stored in glass tube at minus -20 °C 
until HPLC analysis. 
Extraction of AFB 1 
AFB1 was extracted by addition of300 µl ofmethanol to the 
yeast residue and shakenl 0 min. The mixture was centrifuged 
at 9,200xg for 10 min, at4 °C. The supematant was taken off 
for analysis by HPLC. 
Extraction of ZEA 
ZEA was extracted by 300 µl of mixture water/acetonitrile 
(AcN) (1/3). The mixture was shaken for 10 min, and then 
centrifuged at 9,200xg during 10 min. The supematant was 
recovered and used for HPLC. 
Chromatographie conditions 
Mycotoxin concentration was analysed by HPLC with fluo­
rescence detection. Unbound mycotoxin was analysed using 
20 µl of the supematant. Bound mycotoxin was analysed 
using 20 µl of the extract. HPLC system (ICS, France) was 
equipped with an injector 20 µl loop, a C18 spherisorb col­
umn (Prontosil; 25 x 0.4 cm) with inner porosity of 3 µm, 
and a fluorescence detector Shimadzu Fluorescence 
Detector RF-lOAXK. The HPLC was run in a thermostatic 
room (25 °C). 
Zearalenone analysis 
The mobile phase was acetonitrile/water (70:30, v/v) at a flow 
rate of0.5 ml/min. The spectrofluorimetric conditions were of 
275 nm for ZEA excitation and 450 nm for emission. 
Ochratoxin A analysis 
The mobile phase for separation of OTA was methanol/ 
acetonitrile/natrium acetate 0.005 M (0.68 g/1 of water) 
(300:300:400, v/v/v) at a flow rate of 0.5 ml/min. The 
spectrofluorimetric conditions for OTA were 330 nm for ex­
citation and 465 nm for emission. 
Aflatoxin B 1 analysis 
AFB 1 was detected after derivatization in Kobra® cells. 
The mobile phase was methanol/acetonitrile/water 
(200:200:600, v/v/v) added with 119 mg/l of kalium bro­
mide and 350 µl/l of nitric acid 4 M, at a flow rate of 
0.5 ml/min. The spectrofluorimetric conditions for AFB1 
were 362 nm for excitation and 425 nm for emission. 
Separation for simultaneous evaluation of the three toxins 
To separate in one run AFB1 , OTA and ZEA, HPLC was run 
using gradient conditions. 
Phase A: methanol/acetonitrile/water (200:200:600) + 
ammonium formate 0.34 g (6.5 mM). The pH was ad­
justed by addition to formic acid till pH 3 .5. 
Phase B: methanol/acetonitrile/water (350:350:300) + 
ammonium formate 0.34 g (6.5 mM). The pH was ad­
justed by addition to formic acid till pH 3.5. 
The gradient was run as follows: TOmin 100 % A, Tl 5min 
100 % A, T25min 65 % A, T40min 65 % A, T60min 100 % B 
(0 % A), T70min 100 % B, T75min 100 % A 
The elution times were 27.5 min for AFBl, 60.7 min for 
ZEA, and 61.9 min for OTA (see Fig. Sl). 
Quantitation of the percentage of mycotoxins bound 
Percentage of adsorption was calculated either using amount 
of remaining mycotoxin in the supematant or using mycotoxin 
bound on the residue. 
where Ci is the initial amount of mycotoxin; Cs the amount of 
mycotoxin in the supematant 
% binding = Cr/Ci x 100, 
where Cr is the amount extracted from the residue. 
Statistical analysis 
For the comparison of binding capacities of several yeast­
based products when mycotoxins are in binary or temary 
mixture, the results are expressed as means±SD. Data were 
analysed by one way analysis of variance, and multiple com­
parisons of each treatment were calculated by applying the 
Tukey test (Keppel 1973). 
Results 
Development of an in vitro screening method for mycotoxin 
binding 
Evaluation of the best relative concentrations of binder 
and mycotoxin 
The physical properties ofmycotoxins like polarity, solubility, 
size, specific shape and in the case of ionized compounds, 
charge distribution and dissociation constants play a signifi­
cant role in the binding processes. For this reason, the binding 
tests have been done at different pHs to mimic the gastroin­
testinal tract. 
Binding capacity ofYCW against 2 µg of AFB1 or 20 µg 
of ZEA dissolved in buffer was tested using increasing 
amount of YCW in different buffers. The final volume of 
incubation was 1 ml. Control tube contained only AFB1 or 
ZEA in buffers and was incubated in the same conditions to 
test the stability of the mycotoxin in the buffer. After 90 min of 
incubation tubes were centrifuged and the amount of AFB1 or 
ZEA in the supematant and in the residue were analysed. 
Based on remainingAFB1 in the supematant compared to 
the control tube, no adsorption could be observed with 1 mg of 
yeast-based product, whereas it seems that 50 mg of YCW 
was highly efficient to adsorb 2 µg of AFB 1 (Fig. 1). 
Nevertheless, analysis of AFB1 in the residues did not show 
Fig. 1 Binding efficacy of 
2 µg/ml AFB1 by increasing 
amounts ofyeast cell wall (Y0) in 
different buffers: pH 3 (white); pH 
5 (black); pH 7; (grcy). The data 
are expressed as percentage of 
binding calcwated on amount of 
ABF 1 remained in the supernatant 
in the presence of 1, 5 or 
50 mg/ml yeast; or based on 
mycotoxin bound on yeast cell 












relevant AFB 1 adsorption at pH 3 and pH 7 with this high 
amount ofYCW. Indeed, the percentage of adsorption calcu­
lated on AFB 1 extracted from the residue was 8 %, 45 % and 
2 % at pH 3, pH 5 and pH 7, respectively. 
Conceming ZEA, the % of adsorption increased with the 
amount of YCW. With 50 mg/ml of yeast whatever the pH, 
again it seems that almost 100 % of ZEA were adsorbed. 
N evertheless, based on ZEA in residue the % of adsorption 
is about 60 % at pH 3; 80 % at pH 5; 55 % at pH 7. 
Influence of the pH on jluorimetric response of mycotoxin 
The reason of the unexpected high adsorption seen above is 
due to the fact that large amount ofYCW ( 50 mg/ml) modified 
the pH of the buffer which was dramatically lowered 
(Table 1). 
The fluorimetric response of AFB 1 but also of ZEA was 
lower in acidic condition (Fig. 2), and thus virtually less 
mycotoxin was detected when they are analysed directly on 
supematant leading to a misinterpretation on high adsorption. 
In contrast in the same conditions (2 µg/ml OTA; 50 mg/ml 
YCW) a lower % of adsorption as expected compared to OTA 
found in the residue was observed. Acidification of media by 
YCW in the case of OTA, virtually increases the amount of 
residual OTA in supematant because fluorimetric response is 
higher at pH 3 compared to pH 5 or pH 7 for OTA ( see 
Fig. S2). 
Using 5 mg YCW/ml, the pH of the buffer was stable 
whatever the buffer (Table 1 ). 
Table 1 Stability of pH in the presence ofyeast (50 or 5 mg/ml) 
Water pH3 pHS pH7 
6.5 3 5 7 
1.63 2.5 4.08 5.5 
4.5 3.1 4.9 6.99 
Initial pH 
Without yeast 
With yeast (Y0) (50 mg/ml) 





5 50 50 residue 
Amount of yeast cell wall engaged in mg 
For all of these reasons, further experiments have been 
done with 5 mg of YCW pre-incubated 5 min in the buffer 
followed by the addition of a minimal volume (10 µl) of 
mycotoxin solved in methanol in a final volume of 1 ml buffer. 
Evaluation of the best incubation time and the stability 
ofbinding 
Figure 3 shows the kinetic ofbinding of ZEA. Whatever the 
mycotoxins and the concentrations of mycotoxin, the adsorp­
tion equilibrium was reached before 15 min, with almost no 
change after longer incubation times. The adsorption of ZEA 
was better at pH 5 than at pH 3 or 7 (Fig. 3). The maximum of 
adsorption reached 80 % at pH 5 and 60 % at pH 3, whatever 
the concentration of ZEA. The adsorption of OTA was around 
50-60 % for 0.5 µg/ml in buffer pH 3 (Fig. 4). At pH 5, the
adsorption of OTA was negligible. No adsorption of OTA
could be observed in pH 7.
As a plateau was reached after 15 min of incubation, the 
following experiments have been done with 15 min incuba­
tion time. 
Equilibrium points at different pH values/validation step 
of the in vitro method 
To check the best pH and validate concentration ranges, 
increasing amounts of mycotoxins were incubated with fixed 
concentration ofbinder (5 mg) during 15 min at 37 °C. The 
binding capacities were calculated using both the amount of 
mycotoxin remaining in the supematant and the amount of 
mycotoxins bound on the residue. 
As no binding of AFB 1 can be observed with Y0, equilib­
rium point has been evaluated only with ZEA and OTA. 
Adsorption equilibrium was established when the quantity of 
the toxin being adsorbed (Qeq) was equal to the quantity being 
desorbed. Tuen, the equilibrium concentration in solution 
( Ceq) remained constant. Whatever the pH, the isotherm 
curves drawn using mycotoxins in the supematant, are similar 
Fig. 2 Calibration curves and 
fluorescence signal of ZEA 
solved in different buffers: red
triangle: methanol, blue diamond:
buffer pH 3; pink square: buffer 
pH 5; green circle: buffer pH 7 
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to curves drawn using mycotoxins in the residue (see Figs. S3 
and S4). This lead to the conclusion that evaluation could be 
done using only the amount of mycotoxin in the supernatant 
or both data can be mixed. 
For ZEA whatever the concentration, the percentage of 
binding was around 60 % at pH 3 or pH 7, and 70 % at pH 
5. The saturation point was not reached even with 80 µg/ml
(Fig. 5). The % of binding of OTA increased with the con­
centration of ochratoxin from 0.05 to 5 µg/ml. Whatever the
concentration, the OTA binding was better at pH 3 than at pH
5, and no adsorption occurred at pH 7. A saturation ofbinding
was reached at 5 µg/ml (Fig. 6).
Simultaneous binding ofZEA and OTA 
To check if the presence of one mycotoxin can modify the 
adsorption of another, ZEA (1 or 20 µg/ml) and OTA (0.5 or 
2 µg/ml) were incubated together with 5 mg of Y0 in buffer 
pH 3 and pH 5. The binding of low concentration of ZEA 
(1 µg/ml) in the presence of OTA was significantly reduced 
(50 % vs. 60 %) at pH 3 (p<0.05) and slightly decreased 
( 68 % vs. 7 5 % ) at pH 5. In contrast with higher amount of 
ZEA (20 µg/ml), the binding ofZEA at pH 3 was significantly 





















Fig. 3 Binding kinetic ofZEA. Data are expressed as average percentage 
ofbinding of ZEA (20 µg/ml), calculated taking into account amount of 
ZEA in the supernatant and on the residue. Incubation in different buffers: 
pH 3 (black); pH 5 (white); pH 7 (grey) in the presence of 5 mg/ml of 
Yeast cell wall (Y0) 
2 3 4 5 6 
concentration of ZEA in µg/ml 
5, the binding was similar when ZEA was alone or in mixture 
(Fig. 7). Concerning OTA, the presence of low concentration 
of OTA (0.5 µg/ml) in the mixture favoured the adsorption of 
this toxin on YCW whatever the pH. For higher concentration 
(2 µg/ml), at pH 3 the adsorption was similar, and a trend to 
decrease was observed at pH 5. For AFB, the presence of the 
other mycotoxins decreased the adsorption of low concentra­
tion of AFB1 at pH 3 (18 % vs. 30 %). The decrease was 
significant (p<0.01) at pH 5 (5 % vs. 22 %). In contrast for 
high concentration, the adsorption of AFB1 was similar at pH 
3 (about 20 %) and a decrease at pH 5 was observed (5 % vs. 
10%). 
Comparisons of several yeast-based products on adsorption 
of mycotoxins 
Comparison of the binding capacity of nine yeast-based 
products using the new validated in vitro screening method 
Nine yeast-based products (Table S1) were used to evaluate 
the pertinence of the new in vitro procedure to compare 
e:fficacy to bind the three mycotoxins (AFB 1 , ZEA, OTA). 
The incubation was done only in buffer pH 3 (citrate) as it was 
the buffer for which relevant adsorption has been observed for 
the three mycotoxins in the presence of 20 µg/ml ZEA or 
0.5 µg/ml AFBl or 0.5 µg/ml OTA individually. 
The percentage of adsorption of ZEA ranges from 30 % to 
60 %. The less effective products are product Yl, Y2, Y7 and 
Y8 (about 30 %). Three ofthem are from brewer origin. The 
e:fficacy ofproducts Y4, Y6, Y9, Y3 and Y5 is almost similar 
(about 60 %). The percentage of adsorption of ZEA on char­
coal was 99.6±0.4 %. 
The % ofbinding of AFB1 ranged from 15 % (products Y2, 
Y9 and Y6) to 45 % (product Y5). The percentage of AFB1 
binding on charcoal was 99.9±0.05 %. 
The% ofbinding of OTA ranged from 40 % (products Yl, 
Y2) to 70 % (product Y3). There was almost no difference 
between binding capacity ofproducts Y3, Y4, Y5, Y8, Y9 for 
Fig. 4 Binding kinetic of OTA. 
Data are expressed as average 
percentage ofbinding of OTA 
(0.5 µg/ml), calculated taking into 
account amount of OTA in the 
supernatant and on the residue. 
Incubation in different buffers: 
pH 3 (black); pH 5 (white); pH 7 
(grey) in the presence of 5 mg/ml 









OTA (more than 65 %). The% ofbinding of OTA on charcoal 
was 98.7±0.3 %. 
The product Y5 (inactivated yeast-based product enriched 
in glutathione) seemed to be the most interesting products as it 
bound the three mycotoxins to an extent higher than 50 % for 
OTA and ZEA and 45 % for AFB 1 . 
Comparison of the adsorption of two or three mycotoxins 
simultaneously on several yeast products 
To test if the binding of one toxin was modified by the others 
we tested the binding capacities of the several products in two 
conditions: (1) ZEA (20 µg/ml)+AFB (0.5 µg/ml); (2) ZEA 
(20 µg/ml)+ AFB (0.5 µg/rnl)+OTA (0.5 µg/rnl) (Fig. 8). 
The simultaneous presence of ZEA with OTA and AFB 1 
modified the % of binding on yeast products. Depending on 
the products this adsorption could be increased or decreased. 
With yeast products Yl and Y7 (YCW brewer), Y9 ; Y6 
(YCW baker) and Y8 (alcoholyeast) the simultaneous pres­
ence of the three mycotoxins increased the binding of ZEA. 
This increase was already observed when ZEA was only in the 
presence of AFB 1(data not shown). 
With yeast products Y3 (Se Yeast) and Y5 (GSH Yeast), 
the binding of ZEA was similar when ZEA was alone or in the 




in the presence only of AFB 1 . With product Y2 (YCW from 
brewer) a trend of decreasing ZEA binding was observed 
when ZEA was in the presence of AFB 1 or both toxins. 
OTA binding is increased on Y7, whereas it is decreased on 
products Yl, Y2, Y3, Y 4 ,  Y9 when the two other mycotoxins 
are simultaneously present (Fig. 8). 
Discussion 
Adsorption on the cell wall surface is an interaction between 
the toxins and functional groups of the cell surface, based on 
physical adsorption, ion exchange and complexation. The cell 
walls harbouring polysaccharides (glucan, mannan), proteins 
and lipids exhibit numerous different and easily accessible 
adsorption centers as well as different binding mechanisms 
(i.e., hydrogen bonds, ionic or hydrophobie interactions 
(Huwig et al. 2001; Ringot et al. 2007). On the other hand, 
the properties of the adsorbed mycotoxins, like polarity, solu­
bility, shape and charge distribution also play a significant role 
(Huwig et al. 2001; Avantaggiato et al. 2005). 
Most studies conceming the effects of mycotoxins binders 
are focused on AFB 1 . OTA and ZEA were selected in addition 
to AFB 1 as mode! mycotoxins for the current study due to 
their very different structure and physico-chemical properties 
and, due to their toxic properties notably in pig husbandry, 
Fig. 5 ZEA binding of 
increasing amount of ZEA in 
different buffers in the presence of 
5 mg/ml Y0. Percentage of ZEA 
binding in function of initial 
concentration of ZEA and 
according to the pH: pH 3 (black);
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Fig. 6 OTA binding of 
increasing amount of OTA in 
different buffers in the presence of 
5 mg/ml YO. Percentage of OTA 
binding in function of initial 
concentration of OTA and 
according to the pH: pH 3 (black); 













which is considered as the most sensitive animal species 
(EFSA 2004a, b ). OTA has a carboxyl group at the phenylal­
anine moiety and a phenol group at the dihydroisocoumarin 
part with a pKa of 4.4 and 7.3, respectively. Being a 
polyaromatic molecule, OTA is hydrophobie when unionized. 
ZEA is a resorcyclic acid lactone. It has a pKa of 7 .62 and is 
also a weak acid due to the presence of the diphenolic moiety. 
ZEA will be found almost completely in its deprotonated form 
at pH 8.4. (Dakovic et al. 2005). 
The aim of the present work was to adapt a reliable method 
to explore, using an in vitro test, the e:fficacy of mycotoxin 
adsorption on a natural organic adsorbent made of isolated 
S. cerevisiae cell wall fraction.
Originally, in vitro tests have been performed at a defined 
pH, sometimes acidic (Kurtbay et al. 2008), but more often at 
a neutral pH (Carvet et al. 2010; Yiannikouris et al. 2004) and 
using a single mycotoxin concentration (Shetty and Jespersen 
2006). The methods of selection using a unique mycotoxin 
concentration may lead to erroneous result when the concen­
trations of mycotoxin changed (Shetty and Jespersen 2006; 
Bueno et al. 2007; Pizzolitto et al. 2011). Next to single 
concentration experiments, the evaluation of adsorption 
Fig. 7 Comparison ZEA or OTA 90 
binding in mixture in the presence 
of 5 mg/ml YO either in buffer pH 80 
3 or pH 5. Percentage of ZEA 70 
binding: black (alone); light grey
(in the presence of OTA); i: 60 @ 0 percentage of OTA binding: white ·i 50 
( al one); dark grey (in the presence 0 
of ZEA). Significant differences i 40 
of ZEA binding in mixture � 30 
compare to ZEA alone 
@@p<0.01, @p<0.05. Significant 20 
differences of OTA binding in 
10 
mixture compare to OTA alone: 
**p<0.01, *p<0.05 0 
0,05 0,5 2 5 10 
Concentration of OTA in µg/ml 
isotherms have been recommended to characterize mycotoxin 
adsorption (Ringot et al. 2007; EFSA 2009; Joannis-Cassan 
et al. 2011). Under defined conditions, an adsorption equilib­
rium is reached at which the quantity of the toxin being 
adsorbed is equal to the quantity being desorbed. Table 2 
summarizes the different protocols used for testing yeast bind­
ing capacity of mycotoxins. 
However, the binding affmity of a polar substance is influ­
enced by pH and, therefore, it is recommended to measure 
adsorbent characteristics under the conditions of the gastroin­
testinal tract at neutral, acid and basic pH (Sabater-Vilar et al. 
2007). Previously, it has been shown that adsorption of ZEA 
and AFB1 by mineral clays and humic acid polymers, respec­
tively, is pH-dependent (Dakovic et al. 2005; Ye et al. 2009), 
and that the transition to alkaline conditions may lead to 
desorption. 
The first step of this study was to defme the best ratio 
(binder/mycotoxin) using the most common incubation time 
(90 min) and temperature (37 °C) during the analysis 
ofresidual mycotoxins in the supematant. Comparison with 
real amount of mycotoxin bound in the pellet, pinpointed 
inaccurate conclusion of high biosorption with huge amount 
** 
* 
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ofYCW both with AFBl and ZEA. High quantity ofYCW 
(50 mg/ml) even in buffer solution lowered significantly the 
pH, modifying the analytical performance leading to incorrect 
analytical :findings and as consequence to a rnisclassification 
ofbinder ability. Such interference with analytical method of 
OTA has been previously observed (Bazin et al. 2013). 
Yiannikouris et al. 2013 excluded data obtained with pH 7 
because ZEA eluted in two peaks instead of a single peak with 
the pH values of 3.0 and 5.0. Another interference with 
analytical method was due to the precipitation of the myco­
toxins over some concentrations (> 10 µg/ml for OTA; 
>60 µg/ml ZEA). This was also observed by Yiannikouris
et al. (2013), who reported a large variation between replicate
samples from 60 µg/ml of ZEA. Thus, for avoiding any
interference for the subsequent experiments, the incubations
were done with 5 mg/ml of binder in the presence of the
mycotoxins solved in methanol.
Secondly, the best incubation time was checked. By vary­
ing the incubation time, no significant difference in the 
amount of AFB1 , ZEA or OTA removed from YCW were 
observed. The process was fast, since in less than 5 min ( data 
not shown) the YCW was able to bind the same amount of 
mycotoxin as in 90 min. This result was consistent with those 
of Pizzolitto et al. (2012) and Shetty et al. (2007), who have 
not observed differences between 1 min and 6 h, or 0.5 and 
12 h of time contact, respectively. Fifty minutes has been 
chosen for the following experiments. 
Third, the modelling of mycotoxin adsorption was per­
formed to characterize OTA and ZEA adsorption at neutral, 
acidic and basic pHs and with increasing mycotoxin concen­
trations to evaluate the robustness of the method for forthcom­
ing assessments of new mycotoxin adsorbents. There was 
almost no pH effect on ZEA adsorption ( eventhough the 
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is almost independent of the concentrations of ZEA. In con­
trast, OTA was only correctly bound at pH 3. Moreover, OTA 
binding was dependent on its concentration (0.05-10 µg/ml). 
It was always linear at low values of OTA and showed the 
transition to a plateau with higher toxin concentrations. Such 
curve can be modelled using Hill model (data not shown) 
indicating several binding sites, and a putative cooperative 
effect. The slight decrease observed with highest OTA dose 
could be explained by the fact that yeast has several binding 
sites for OTA, and a cooperative effect play a major role. The 
first molecule of OTA bound on YCW modifies the affmity 
for the following one. Even a decreasing capacity with OTA 
concentration over 5 µg/ml suggests a dynamic equilibrium 
between the binder concentration and relative binding effi­
ciency. The process reached equilibrium between bound 
toxins (occupied sites) and unbound toxins (free sites) and 
therefore a reversible process could be involved as it was 
demonstrated with AFB1 by Pizzolitto et al. (2012) and with 
ZEA by Yiannikouris et al. (2013). These results indicate that 
the sorption capacity of yeast products depends greatly on the 
initial concentration of the mycotoxin. Therefore, a compari­
son from single tests, frequently used in previous studies 
by assuming the linear sorption of the mycotoxin, is not 
adequate. When the isotherms are not linear, the com­
parison of adsorption capacity of yeast products could 
lead to opposite conclusions, depending on the initial 
mycotoxin concentration tested. Thus, adsorption of my­
cotoxin by yeast products was not a linear phenomenon, 
which means that isotherm studies are necessary to com­
pare the sorption capacity of yeast products. Analysis of 
individual results of the efficient isotherm models confirmed 
that adsorption capacity and affinity depend on the interac­
tions between mycotoxin, adsorbent and pH. Therefore, iso­
therm models to describe adsorption equilibrium cannot be 
Table 2 Comparison of the method use for binding screening 
Study Mycotoxins (concentrations) Binder (concentration) pH (buffer) Incubation time 
(incubation volume) 
Shetty and Jespersen AFB1 (5 µg/ml) Yeast/lactic bacteria Phosphate buffer 30 min 37 °C 
2006 (Unknown amount) (pH unknown) (1 ml final volume) 
Sabater-Vilar et al. ZEA (! µg/ml) Yeast (1; 2.5; 5 mg/ml) pH 2.5 (citrate buffer) 1 h 37 °C 
2007 DON (1 µg/ml) (1 ml final volume) 
Carvet et al. 2010 DON (1 and 2 mM) Yeast (1 mg/ml) pH 3 and 7 90 min 37 °C 
(1 ml final volume) 
Fruhauf et al. 2012 AFBI 0.2 mg/1 Yeast (10 mg/5 ml) pH 3 and 6.5 1 h 37 °C 
ZEA 0.5 mg/1 (10 ml final volume) 
Pereyra et al. 2012 AF (2 µg/ml) Yeast (5 concentrations pH2 and 6 30 min 37 °C 
ZEA (1 µg/ml) ranging 2-500 µg/ml) (1 ml final volume) 
Manafi et al. 2009 AF (500 ppb) Herbai binder including Citrate buffer adjusted 3 h 37 °C 
OTA (500 ppb) minerais and antioxidant) pH 4.5 and 6.5 (250 ml final volume) 
T-2 (2 ppm)
Santos et al. 2011 OTA (0.1 µg/ml) Bentonite Successive pH (pH 7.2; 30 min 39 °C (pH 7.2), 
ZEA (0.5 µg/ml) Humic acid (5 concentrations pH3;pH 8.4) then 1 h (pH 3); then 
ranging 0.5-5 mg/ml) 3 h (pH 8.4) 
(30 ml final volume) 
Santos et al. 2011 Isothenn Bentonite Successive pH (pH 7.2; 30 min 39 °C (pH 7.2), 
OTA (0.025-0.1 µg/ml) Humic acid pH3;pH 8.4) then 1 h (pH 3); then 
ZEA (0.125-1 µg/ml) ( 5 concentrations ranging 3 h (pH 8.4) (30 ml 
0.5 -5 mg/ml) final volume) 
Joannis-Cassan et al. lsothenn Yeast pH 3 (citrate) 15 min 37 °C 
2011 AF (1-10 µg/ml) (5 mg/ml) pH 5 (acetate) 
OTA (1-10 µg/ml) pH 7 (phosphate) 
ZEA (1-80 µg/ml) 
Yiannikouris et al. lsothenn Yeast (100 µg/ml) In water 90 min 37 °C 
2003,2004 ZEA (2-20 µg/ml) (1 ml final volume) 
Yiannikouris et al. Isothenn Yeast (1 mg/ml) pH 3 (citrate) 90 min 39 °C 
2006 ZEA (2-100 µg/ml) pH 6 (succinate) (1 ml final volume) 
pH 8 (Tris) 
Ringot et al. 2005 lsothenn Yeast water 90 min 4°, 25°, 37 °C 
OTA (0.5-10 mg/1=5-100 µg/10 ml) (500 mg/10 ml water) (10 ml final volume) 
Ringot et al. 2007 Isothenn Yeast water 90 min 25 °C 
OTA (0.5-10 mg/1=5-100 µg/10 ml) (500 mg/10 ml water) (10 ml final volume) 
Yiannikouris et al. Isothenn Yeast pH 3 ( citrate buffer) 90 min 37 °C 
2013 ZEA (10--50 µg/ml) (10 mg/ml) pH 5 (Acetate buffer) 
Pizzolitto et al. 2012 lsothenn Yeast phosphate buffer 30 min 37 °C 
AFB1 (2-20 µg/ml) (100 µg/ml) (pH unknown) 
Pizzolitto et al. 2012 lsotherm Yeast pH 7.3 (phosphate 30 min 37 °C 
AFB1 (0.3-2.5 µg/ml) (2.8-5 X 107 cell/ml) buffer) 
Armando et al. 2011 lsothenn Yeast pH 7.3 60 min 37 °C 
AFBl (50--500 ng/ml) (107 cell/ml) 
Armando et al. 2012 Isotherm Yeast pH7.2 60 min 37 °C 
OTA (1-100 µg/ml) (107 cell/ml) 
ZEA (1-50 µg/ml) 
generalized, but serve as a valuable tool to identify and com­
pare new products (Joannis-Cassan et al. 2011). 
>OTA and involved both the (1-3)-13-o-glucans and the
(1-6)-/3-0-glucans. Alkaline conditions, owing to their
destructuring action on glucans, were favorable only for the
adsorption of patulin (Guo et al. 2012). Using molecular
mechanics, Yiannikouris et al. (2004, 2006) found that hy­
droxyl, ketone, and lactone groups are involved in the forma­
tion of both hydrogen bonds and van der Waals interactions
between aflatoxins B 1, deoxynivalenol, ZEA and patulin, and
The stereo chemistry and hydrophobie properties ofmyco­
toxins are of prime importance and account for the differences 
in their affmity for !3-0-glucans. The environmental condi­
tions such as pH were determining for the stability of the 
toxin-glucan complexes generated. Acid and neutral condi­
tions gave the highest affinity rates for AFB 1 >deoxynivalenol 
j3-o-glucans (Yiannikouris et al. 2006). Protonation of OTA is 
changed in the pH course, as it has a pKa of 4 .4 and 7.3. At pH 
3.0, ahnost all OTA will be in the neutral (non-charged) form, 
while at pH 7.4 it will be present as a monoanion or a dianion, 
and at pH 8.4 most OTA will be in the dianion form (Santos 
et al. 2011; Bazin et al. 2013). 
As the balance ( amount of mycotoxin adsorbed + amount 
in the supernatant) was correct and the acidic pH was the best 
one for the three mycotoxins, we compared several yeast 
derivatives by incubating fixed amount of mycotoxins 
(0.5 µg/ml of OTA or AFB1 and 20 µg/ml of ZEA, individ­
ually or in binary or ternary mixture) and analysing the bind­
ing capacity taking into account the mycotoxins remaining in 
the supematant and bound on the residue. This method allows 
making discrimination between the different products 
against the three mycotoxins tested. It is also applicable 
to analyse binding capacity ofyeast-based products in multi­
contamination conditions and gives a piece of information 
about interaction ( cooperative effect/competition). 
The products Y9 and Y 4 (YCW from baker) and Y 5 (GSH 
yeast), had a similar efficacy for ZEA and OTA binding. 
Products Yl, Y2 (YCW from brewer), Y3 (Se yeast), Y7 
(YCW from brewer) and Y8 (alcohol yeast) bound more 
OTA than ZEA. On1y Y6 (YCW from baker) bound a little 
bit more ZEA than OTA. This later product Y 6 was the best 
binder for ZEA, whereas it was the worst for AFB 1 • Product 
Y5 (GSH yeast) seems to be an interesting product as it 
boundthe three toxins with an efficacy close to 50 % (AFB 1) 
and over 60 % (ZEA and OTA). In the same way, product Y3 
(SE yeast) was a relatively interesting binder against AFB1 , 
and good binder for the two others mycotoxins. Nevertheless, 
these two latter products are not YCW but enriched yeasts. 
Thus the decrease could be due to some biotransformation of 
the mycotoxins and not exlusively due to binding. 
In general, when the binding of ZEA increased in the 
presence of the two other toxins, the binding of OTA de­
creased (i.e., Yl [YCW brewer], Y9 [YCW baker]). In case 
of an increase of ZEA binding associated with a decrease of 
OTA binding ( or the reverse), this means that both toxins act 
on the same binding site, but with a different affinity; or two 
binding sites exit and the binding of one mycotoxin modifies 
the binding capacities of the other site (cooperative affect). 
There was also a competition between OTA and AFB1 . 
Although AFB1 binding on Yl and Y9 was decreased in the 
presence of ZEA, this decrease was no more pronounced 
when OTA was also present. In contrast, with product Y7 
the binding of both ZEA and OTA increased, indicating a 
cooperative effect. 
Product Y6 (YCW baker) was the sole product for which 
ZEA's binding increased in the presence of the two other 
mycotoxins without decreasing the adsorption either of 
AFB1 or OTA. Probably the binding sites are multiple and 
different for each mycotoxin. 
These data could be explained by cooperative inter­
action. The biosorption capacity of yeast 13-o-glucans 
in vitro was shown to be modulated by the amount of 
ZEA added to the medium according to a cooperative 
phenomenon. The binding of the first mycotoxin mole­
cules induces conformation changes in j3-glucans that 
facilitates access to new sites of fixation improving 
binding efficiency until saturation of all sites of adsorp­
tion (Yiannikouris et al. 2003, 2004). 
In this study, no correlation could be draw between myco­
toxins binding capacity and the amount of glucans and/or 
mannan. This data is in line of that of Carvet et al. (2010), 
who tested different 13-glycans and shown that bound 
type (1-3 or 1-6) or the ramifications might not be 
sufficient criteria to characterize their adsorption prop­
erties. In contrast to ZEA binding, the AFB 1 binding did not 
correlate with the mannoligosaccharides (MOS) and glucan 
content of the investigated products (Fruhauf et al. 2012; 
Pizzolitto et al. 2012). 
Pereyra et al. 2012 tested AFB1 and ZEA binding capacity 
of two YCWs differing in their chemical compositions. The 
first YCW contained5.9 and 17.4 % of mannans and 13-
glucans while the second YCW contained a higher percentage 
ofmannans (21 %) and 13-glucans (23 %), respectively. The 
both YCWs adsorbed ZEA at the studied pH conditions. 
Conceming ZEA at pH 2 there was a much more pronounced 
cooperative effect than at pH 6 with the first YCWl. It was the 
opposite for second YWC. The authors concluded that ZEA 
binding can be attributed to the presence of j3-glucans in the 
walls as the effect of pH on binding constants was systematic 
and similar for both YCW. They bound both a similar 
amount of AFB 1 at pH 2. The cooperative indexes 
obtained for both adsorbents were higher at pH 2. In 
contrast, they bound much less AFB1 at pH 6. The interaction 
of AFB 1 with glucomannan ofYCW was presumably through 
hydrogen bonds (Pereyra et al. 2012). 
Altogether, to be able to obtain a good and reproducible 
response to screen different adsorbent materials, ZEA, 
AFB 1 or OTA should be dissolved in methanol, because 
dissolution directly in buffer induces a precipitation and 
distorts the results. Mycotoxins should be dissolved in 
methanol to appropriate concentration (lOOx the final 
concentration required in the test tube) and 10 µl of 
this solution is added to the yeast-based product (5 mg) 
pre-incubated in the buffer (990 µl). In these conditions, 
the balance (amount of mycotoxin adsorbed + amount 
in the supematant) is correct. With this protocol, it is 
possible to make a pre-screening of adsorbent capacities 
against several mycotoxins present together in range of my­
cotoxin concentrations corresponding to permitted value in 
food and feed. This method will be applied to other adsorbent 
materials such as bentonite and humic acid, and to other 
mycotoxins including deoxynivalenol or fumonisins. 
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